Cullinan Associates Inc. Acquires 600 Shares of Eli Lilly and Company (NYSE:LLY)

Cullinan Associates Inc. increased its position in Eli Lilly and Company (NYSE:LLY – Get Rating) by 50.0% in the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 1,800 shares of the company’s stock after purchasing an additional 600 shares during the […]